The real long term play for the clinics is to be cashflow positive and ready for PBS/Medicare funding.
There's a lot of drugs thay cost $1,000+ a month that customers dont know about because they pay $14-30. IHL having private clinics ready and cashflow positive with not huge growth is fine, as long as they are building coverage and expertise - if and when funding builds, its ready.
The amount of well off people I know who spend $10k+ a year on treatments, it wouldn't shock me to see some uptake, but it certainly isn't going to be raking in millions from day one.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-16656
-
- There are more pages in this discussion • 3,241 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online